CALTH. Inc Logo

CALTH. Inc

Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.

402420 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 54, 321호(시흥동, 기업성장센터), 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CALTH Inc. is an in vitro diagnostics (IVD) company that develops and manufactures rapid diagnostic solutions. The company provides innovative healthcare services for point-of-care testing (POCT), self-testing, and precision medicine. Its core business is built upon two proprietary technologies: an "Engineered Nanotrap" system for high-sensitivity sample preprocessing and a deep learning-based algorithm for the rapid and accurate analysis of Lateral Flow Assay products. CALTH's mission is to improve quality of life by delivering fast, accurate, and low-cost diagnostic tools. The company operates in facilities certified with KGMP and ISO 13485:2016.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CALTH. Inc and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 82.8 KB
2025-08-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 88.1 KB
2025-08-06 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.2 KB
2025-07-29 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 35.1 KB
2025-07-25 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.2 KB
2025-07-17 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 54.6 KB

Automate Your Workflow. Get a real-time feed of all CALTH. Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CALTH. Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.